Topics and Expertise: nanotechnology

Desai inducted into International Academy of Medical and Biological Engineering

Fri Oct 11, 2019
Desai
Todd Dubnicoff

Tejal Desai, PhD

Desai was recognized for being a “pioneer in the use of micro and nanoscale materials to deliver protein and cell-based therapeutics.”

Novel diabetes treatment developed in Desai Lab to power SF-area startup

Thu Oct 19, 2017
device alongside a quarter to show size
Encellin

The cell encapsulation device (right) that is being developed by Encellin, a San Francisco–based biotechnology company.

A UC San Francisco-created, insulin-generating implant that utilizes nanotechnology is closer to becoming a real treatment for diabetes, after being acquired by a San Francisco-based startup.

Prien and MacWilliam bequests establish new endowed professorships

Wed Dec 7, 2016
Prien, MacWilliam
Foresight, newsletter of UCSF Office of Gift & Endowment Planning

Ernest Prien, BS ’34 and Mary MacWilliam, EdD, UC Berkeley, 1956

The UCSF School of Pharmacy has established new endowed faculty positions to be held by the chairs of two School departments.

Major funding for The Kidney Project from NIBIB Quantum Program

Tue Nov 3, 2015
artificial kidney prototype
Elisabeth Fall

Bioartificial kidney prototype and components.

The research journey toward building a fully functioning, surgically implantable artificial kidney as an alternative to kidney transplant and dialysis just took another step forward with the announcement of a $6 million grant to The Kidney Project, headquartered at the UCSF School of Pharmacy.

Desai elected to the National Academy of Medicine

Tue Oct 20, 2015
Tejal Desai
Cindy Chew

Tejal Desai, PhD

UCSF School of Pharmacy faculty member Tejal Desai, PhD, has been newly elected to the National Academy of Medicine (NAM), formerly known as the Institute of Medicine (IOM).

Desai Lab develops nanodevices to aid artery repair

Tue Nov 25, 2014
Lance
Kathleen Masterson

Kevin Lance, a graduate student in the Desai lab, holds thin-film blood-vessel wrap being developed to deliver anti-scarring drugs.

Research in the laboratory of Tejal Desai, PhD, is creating new kinds of drug delivery devices to reduce the scarring and inflammation that can undermine stents—metal mesh tubes implanted to prop open blocked arteries, including in the heart.

New NIH funding awarded to the Department of Bioengineering and Therapeutic Sciences in 2011

Fri Apr 13, 2012
New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included a half-dozen on-going projects by BTS faculty:

In-flight programming features bioartificial kidney

Fri Oct 21, 2011
Passengers who travel on American Airlines from September through October 2011 will learn about the surgically implantable bioartificial kidney being developed at UCSF as a permanent solution to end stage renal disease.

SmartPlanet video features The Kidney Project

Fri Dec 10, 2010
Diagram of artificial kidney device highlights filter design.
The implantable bioartificial kidney is explained in this December 6, 2010, SmartPlanet video featuring Shuvo Roy, PhD, a faculty member in the UCSF Schools of Pharmacy and Medicine.

Roy shares promise of bioartificial kidney

Thu Nov 18, 2010
Shuvo Roy, PhD, an engineer and research scientist, is leading a U.S. project to build the world’s first bioartificial kidney to treat end stage renal disease. The goal is to surgically implant this coffee-cup-sized device in a human patient within 5 to 7 years.

Pages